GIP : Glucose-dependent insulinotropic polypeptide an incretin hormone that helps stimulate insulin release in response to meals
Untreated hypothyroidism, severe insulin resistance, or cortisol dysregulation can all reduce tirzepatide appetite-suppressing effects
Interesting fact - Studies show glutathione reduces melanin production by blocking the tyrosinase enzyme
The obesity and metabolic treatment market is projected to be worth billions globally, and companies are now competing not only on clinical efficacy but also on: Market access and pricing strategies Physician education and awareness Patient adoption and long-term adherence Strategic partnerships in high-growth markets like China For example, GLP-1 products such as Wegovy have already demonstrated how strong positioning and demand can rapidly expand a therapeutic category
The Dual Challenge: Obesity and Sarcopenia in Older Age Age-related changes in body composition are characterized by decreased fat-free mass (FFM), which includes reductions in total muscle mass and bone mineral density (BMD), alongside a relative increase in fat mass (FM) [13]
Semaglutide helps control blood sugar in adults with type 2 diabetes